Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma
Authors:
Open Access
- 10 April 2008
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 15 (18) , 1257-1270
Abstract
Reovirus is a promising unmodified double-stranded RNA (dsRNA) anti-cancer oncolytic virus, which is thought to specifically target cells with activated Ras. Although reovirus has been tested in a wide range of preclinical models and has entered early clinical trials, it has not previously been tested for the treatment of human melanoma. Here, we show that reovirus effectively kills and replicates in both human melanoma cell lines and freshly resected tumour; intratumoural injection also causes regression of melanoma in a xenograft in vivo model. Reovirus-induced melanoma death is blocked by caspase inhibition and is dependent on constituents of the Ras/RalGEF/p38 pathway. Reovirus melanoma killing is more potent than, and distinct from, chemotherapy or radiotherapy-induced cell death; a range of inflammatory cytokines and chemokines are released by infected tumour cells, while IL-10 secretion is abrogated. Furthermore, the inflammatory response generated by reovirus-infected tumour cells causes bystander toxicity against reovirus-resistant tumour cells and activates human myeloid dendritic cells (DC) in vitro. Hence, reovirus is suitable for clinical testing in melanoma, and may provide a useful danger signal to reverse the immunologically suppressive environment characteristic of this tumour.Keywords
This publication has 59 references indexed in Scilit:
- Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of ReovirusClinical Cancer Research, 2008
- Immunotherapy of melanoma: a critical review of current concepts and future strategiesExpert Opinion on Biological Therapy, 2007
- Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?Cancer and Metastasis Reviews, 2006
- Sensitization to Apoptosis Underlies Kras D12 -Dependent Oncolysis of Murine C26 Colorectal Carcinoma Cells by Reovirus T3DJournal of Virology, 2005
- IL-6 Produced by Type I IFN DC Controls IFN-γ Production by Regulating the Suppressive Effect of CD4+ CD25+ Regulatory T CellsHuman Immunology, 2005
- Connecting Reovirus Oncolysis and Ras SignalingCell Cycle, 2005
- The role of B-RAF in melanomaCancer and Metastasis Reviews, 2005
- Reovirus oncolysis in human head and neck squamous carcinoma cellsAuris Nasus Larynx, 2004
- Regressing cutaneous malignant melanoma and vitiligo‐like depigmentationInternational Journal of Dermatology, 2004
- Reovirus Type 3 Chemoimmunotherapy of Murine Lymphoma is Abrogated by CyclosporineCancer Biotherapy, 1995